As healthcare delivery systems prepared for a focused period of change, implementation, evaluation, and overhaul from existing systems to rejuvenated processing based on updated regulations and guidelines, the industry can now address the ‘other’ information. By this, we define the coding of medical treatments that are not the primary focus, such as main diagnostic and treatment procedures, and shift focus to the ancillary information. This secondary data also supports and sustains efficiency healthcare delivery. 
Core modeling and methodology is currently focused on the primary information mentioned, with limited directives towards the processes that complete healthcare delivery. Among these included are laboratory, pharmacy, diagnostic measures, and testing integrated with a patient’s treatment plan.
In ensuring that the mandated regulations and medical treatment methodology updates are fully addressed, these ancillary components should be addressed during the initial stages of system upgrade and evaluation. Laboratory, pharmacy, and diagnostic data must be assessed from numerous angles. This may include measuring quantifiable differences and discerning variations in utilization and gaps in process flow. Standard testing methodologies can be applied to data from a patient’s initial visit to information on the utilization and results of laboratory, pharmacy, and diagnostics. Customized testing methodologies can be applied to specific disease, provider, and patient populations to highlight trends or outliers in utilization. Regardless, thorough and accurate implementation of all upgrades is not feasible without the evaluation of components of the treatment process that occur in the later stages.
